Searchable abstracts of presentations at key conferences in endocrinology

ea0081ep1173 | Late Breaking | ECE2022

Primary hyperparathyroidism-induced osteoporosis: lessons from the DENOCINA trial

Lopes Valentim , Lages Adriana

An 89 years old caucasian female patient with antecedents of hemithyroidectomy in 2016 due to benign nodular disease, and actually suplemented with 0.1 mg/day of levothyroxine, was referred to the Endocrinology consultation because of a primary hyperparathyroidism diagnosed in the sequence of the study of an episode of nephrolitiasis that happened in 2012 and a diagnosis of osteoporosis that was established in 2017. A 99mTc-Sestamibi revealed an augmented right inferior parath...

ea0090ep1100 | Late Breaking | ECE2023

Diabetes mellitus secondary to BRCA2 gene mutation: the importance of insulin resistance and genetics in dysglycemia

Lopes Valentim , Brito Patricia , Machado Catarina , De Sousa Lages Adriana

Introduction: Diabetes mellitus (DM) results from a defect in insulin secretion and/or its action. The Breast-Cancer Susceptibility Gene 2 (BRCA2), like BRCA1, is a tumour suppressor gene, and its mutation is associated with an increased risk of breast cancer and, in males, testicular cancer. In patients with the BRCA1/2 mutation, the level of Insulin-like Growth Factor (IGF)-1 and, consequently, the peripheral sensitivity to insulin are reduced, suggesting that this ...

ea0099ep47 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

Mody-3 diabetes: is there a place for GLP-1 receptor agonists use?

Lopes Valentim , Brito Patricia , Ribeiro Rita , Lages Adriana

Introduction: Maturity-onset diabetes of the young (MODY) represents 1 to 2% of all cases of diabetes. MODY-3 is the most prevalent subtype and is characterized by a high sensitivity to sulfonylurea (SU) therapy. To date, we have scarce evidence about the efficacy of other therapies in this population, namely GLP-1 receptor agonists (GLP-1ra). Objective: Evaluate the metabolic impact of GLP-1ra use in MODY-3 patients.Methods: Retro...

ea0092ps1-01-04 | Cancer | ETA2023

Papillary thyroid carcinoma from a thyroglossal duct cyst: a rare association

Lopes Valentim , Brito Patricia , Lages Adriana , Maciel Joana , Pereira Ricardo , Machado Catarina

Introduction: Thyroglossal duct cysts (TDC) are a very frequent congenital neck mass and are mostly benign. Papillary thyroid carcinoma (PTC) originating from a TDC represents an infrequent finding. Usually, the diagnosis is only made postoperatively after cyst’s excision.Case report: A 38-years old female patient was referred to the Endocrinology department due to Graves’ disease. She had been treated with antithyroid drugs for 18 months witho...